Results 71 to 80 of about 978 (163)
Background: Over the past decades, cancer has become the second leading cause of death and morbidities around the world, accounting for nearly 1 in 6 of the total global deaths.
Bhaskaran Unnikrishnan +11 more
doaj +1 more source
Introduction: The recent National Health Accounts 2019-20 data reveals that Out-of-Pocket Expenditure (OOPE) as a percent of Total Health Expenditure is more than 47% which is still higher compared to out-of-pocket health spending in other developing ...
Omkarnath Sivarchaka +2 more
doaj +1 more source
Background On 1 st September 2022, the Cancer Drug List (CDL) was implemented to ensure the long-term affordability of chemotherapy and insurance premiums.
Darren Lee +3 more
doaj +1 more source
Language Design: OOP or not OOP or better OOP
openaire +2 more sources
Is publicly funded health insurance associated with healthcare utilisation and financial protection in India? Evidence from a cross-sectional household survey (CAMS 2022-2023). [PDF]
Bonu S, Bhushan I.
europepmc +1 more source
Do publicly supported generic pharmacies improve financial risk protection? Findings from a nationally representative cross-sectional survey in India. [PDF]
Purohit N +12 more
europepmc +1 more source
Financial burden of older inpatients with multimorbidity in China: a cross-sectional study. [PDF]
Xian B, Paek SC, Jin W, Marohabutr T.
europepmc +1 more source
One size does not fit all: income-sensitive thresholds for catastrophic health expenditure. [PDF]
Dubey JD, Kumar D, Reddy A B.
europepmc +1 more source
Do publicly funded health insurance schemes reduce out-of-pocket expenditure?: Evidence from India. [PDF]
Sharma A.
europepmc +1 more source

